4.8 Article

A De Novo Mouse Model of C11orf95-RELA Fusion-Driven Ependymoma Identifies Driver Functions in Addition to NF-kappa B

Journal

CELL REPORTS
Volume 23, Issue 13, Pages 3787-3797

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2018.04.099

Keywords

-

Categories

Funding

  1. National Cancer Institute (NCI) of the NIH [U54 CA163167, R01 CA195718, U54 CA193461, R01 CA100688, U01 CA105492, U54 CA143798, T32 CA157323, P01CA96832, R01CA129541]
  2. Cancer Research UK
  3. Mathile Foundation
  4. CureSearch
  5. NATIONAL CANCER INSTITUTE [P01CA096832, U54CA163167, R01CA195718, U54CA193461, U01CA141502, R01CA100688] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The majority of supratentorial ependymomas (ST-ependymomas) have few mutations but frequently display chromothripsis of chromosome 11q that generates a fusion between Cllorf95 and RELA (RELA(Fus)). Neural stem cells transduced with RELA Fus ex vivo form ependymomas when implanted in the brain. These tumors display enhanced NF-kappa B signaling, suggesting that this aberrant signal is the principal mechanism of oncogenesis. However, it is not known whether RELA Fus is sufficient to drive de novo ependymoma tumorigenesis in the brain and, if so, whether these tumors also arise from neural stem cells. We show that RELA(Fus) drives ST-ependymoma formation from periventricular neural stem cells in mice and that RELA(Fus)-induced tumorigenesis is likely dependent on a series of cell signaling pathways in addition to NF-kappa B.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available